Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin beta (beta-actin, ACTB) is a highly conserved, ubiquitously expressed cytoskeletal protein and one of six actin isoforms in humans. It is encoded by the ACTB gene and functions as a major component of the cytoskeleton, playing crucial roles in cell shape, mechanical stability, intracellular transport, and regulation of gene expression. Beta-actin is essential for cell motility, migration, and maintenance of cell polarity and is involved in key processes such as actin filament treadmilling and cytoskeletal dynamics. In laboratory practice, it is widely used as a reference standard or loading control in molecular biology assays due to its stable expression. Mutations in ACTB are associated with certain diseases, including diffuse large B-cell lymphoma and Baraitser-Winter syndrome. Beta-actin interacts with diverse actin-binding proteins and participates in numerous cellular processes, but it is not regarded as a direct pharmacological or therapeutic target.
Not applicable for drugs, as beta-actin is not typically a pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin beta (ACTB).